ATE300310T1 - Verfahren zur steigerung von hematopoietischen zellen - Google Patents

Verfahren zur steigerung von hematopoietischen zellen

Info

Publication number
ATE300310T1
ATE300310T1 AT96921229T AT96921229T ATE300310T1 AT E300310 T1 ATE300310 T1 AT E300310T1 AT 96921229 T AT96921229 T AT 96921229T AT 96921229 T AT96921229 T AT 96921229T AT E300310 T1 ATE300310 T1 AT E300310T1
Authority
AT
Austria
Prior art keywords
cells
methods
hematopoietic cells
donor
thrombopoietin
Prior art date
Application number
AT96921229T
Other languages
English (en)
Inventor
Willem E Fibbe
Angelika Grossmann
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE300310T1 publication Critical patent/ATE300310T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/196—Thrombopoietin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96921229T 1995-06-07 1996-05-29 Verfahren zur steigerung von hematopoietischen zellen ATE300310T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,212 US6013067A (en) 1995-06-07 1995-06-07 Methods for increasing hematopoietic cells
PCT/US1996/007880 WO1996040218A1 (en) 1995-06-07 1996-05-29 Methods for increasing hematopoietic cells

Publications (1)

Publication Number Publication Date
ATE300310T1 true ATE300310T1 (de) 2005-08-15

Family

ID=23915172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921229T ATE300310T1 (de) 1995-06-07 1996-05-29 Verfahren zur steigerung von hematopoietischen zellen

Country Status (10)

Country Link
US (1) US6013067A (de)
EP (1) EP0831888B1 (de)
JP (1) JP3058353B2 (de)
KR (1) KR19990022420A (de)
CN (1) CN1190348A (de)
AT (1) ATE300310T1 (de)
AU (1) AU693032B2 (de)
CA (1) CA2223046A1 (de)
DE (1) DE69634982T2 (de)
WO (1) WO1996040218A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
AU2006201129B2 (en) * 1997-05-21 2008-03-13 Genentech, Inc. Novel administration of thrombopoietin
US8313742B2 (en) * 2002-03-29 2012-11-20 Depuy Acromed, Inc. Cell-containing bone graft material
AU2003240512B2 (en) 2002-06-04 2009-11-05 The Board Of Trustees Of The Leland Stanford Junior University Device and method for rapid aspiration and collection of body tissue from within an enclosed body space
US20040028661A1 (en) * 2002-08-07 2004-02-12 Bartelmez Stephen H. Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
ES2462916T3 (es) 2002-09-18 2014-05-26 Janssen Pharmaceuticals, Inc. Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
JPWO2004033499A1 (ja) 2002-10-11 2006-02-09 中外製薬株式会社 細胞死誘導剤
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
AU2005299379B2 (en) * 2004-10-25 2011-06-09 Cellerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
EP1870458B1 (de) 2005-03-31 2018-05-09 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2-STRUKTURISOMERE
CN101262885B (zh) 2005-06-10 2015-04-01 中外制药株式会社 含有sc(Fv)2的药物组合物
KR101367544B1 (ko) * 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
EP1900814A4 (de) * 2005-06-10 2010-07-21 Chugai Pharmaceutical Co Ltd Stellengerichtete sc(fv)2-mutante
KR20090021217A (ko) * 2006-06-14 2009-02-27 추가이 세이야쿠 가부시키가이샤 조혈 줄기세포 증가 촉진제
CN102307989B (zh) 2008-11-14 2015-04-22 生物载体株式会社 用于产生树突细胞的方法
EP2581442A4 (de) * 2010-06-14 2013-11-06 Nissan Chemical Ind Ltd Verfahren zur herstellung blutbildender stammzellen
SG11201805533QA (en) 2016-01-14 2018-07-30 Depuy Synthes Products Inc Composition and methods for cryopreservation of hutc
AU2017216411B2 (en) 2016-02-01 2019-05-16 RegenMed Systems, Inc. Cannula for tissue disruption
WO2017192430A1 (en) 2016-05-02 2017-11-09 Kellogg Company System and method for applying a fastening material to a substrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894440A (en) * 1986-09-17 1990-01-16 Massachusetts Institute Of Technology Method of isolating megakaryocyte stimulatory factor
US4946437A (en) * 1988-12-02 1990-08-07 Bar-Ilan University Method for the stimulation of bone marrow cells
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5571686A (en) * 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets

Also Published As

Publication number Publication date
WO1996040218A1 (en) 1996-12-19
US6013067A (en) 2000-01-11
EP0831888B1 (de) 2005-07-27
CA2223046A1 (en) 1996-12-19
MX9709244A (es) 1998-03-31
EP0831888A1 (de) 1998-04-01
JP3058353B2 (ja) 2000-07-04
DE69634982D1 (de) 2005-09-01
DE69634982T2 (de) 2006-04-27
AU693032B2 (en) 1998-06-18
JPH10510842A (ja) 1998-10-20
CN1190348A (zh) 1998-08-12
KR19990022420A (ko) 1999-03-25
AU6250096A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
Jager et al. Bone marrow concentrate: a novel strategy for bone defect treatment
DE69837491D1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
EP1915440A2 (de) Zusammensetzungen von mit kombinationen verschiedener stamm- und vorläuferzellpopulationen angereicherten zellen, verfahren zur verwendung davon und verfahren zur erstellung privater banken davon
DK1294414T3 (da) Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
US20090016997A1 (en) Autologous/allogeneic human DNA grafting, anti-and reverse aging stem cell, and bone marrow compositions/methods
NO992569D0 (no) FremgangsmÕter for Õ hindre podingsforkastelse i transplantasjon og for fremstilling av en universell genterapi vertcelle ved Õ anvende lymfocytt aktivering (LAG-3)
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
DE69624937D1 (de) Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen
US20160120909A1 (en) Compositions And Methods For The Treatment Of Tinnitus
EP2268293A2 (de) Stammzellenzusammensetzung zur auslösung von transplantattoleranz
US11760976B2 (en) Stem cells and decellularization of tissue matrix from cord tissue
Watanabe et al. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience
Loutit Lymphocytes—The Mackenzie Davidson Memorial Lecture
WO2005105169A1 (ja) 脂肪組織由来幹細胞から骨髄を形成するための組成物およびその方法
RU2160112C1 (ru) Способ приготовления клеточного трансплантата из фетальных тканей
Weinberg Hematopoietic progenitor cell products derived from bone marrow and peripheral blood
US20020100065A1 (en) Production of typed human cells, tissues and organs
Chen et al. Specially modified stromal and immune microenvironment in injected bone marrow following intrabone transplantation facilitates allogeneic hematopoietic stem cell engraftment
Miller Is Regenerative Medicine the Answer to Canine Osteoarthritis?
Henon Peripheral blood stem cell transplantation: critical review
Kevy et al. Point of care concentration of bone marrow
Pavlović et al. Stem Cell Pool: What Are the Best Patterns for Cellular Therapy?
Pigneux et al. Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts
ATE263833T1 (de) Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0831888

Country of ref document: EP

REN Ceased due to non-payment of the annual fee